This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

RenaissanceRe Nabs Two Analyst Endorsements

BOSTON ( TheStreet) -- RenaissanceRe (RNR - Get Report) shares have rallied 15% over the past three months. Two analysts said Friday that the reinsurer's run may continue.

Citigroup analyst Keith Walsh added RenaissanceRe to the investment bank's Top Picks Live list, saying the company is the best-positioned insurer to take advantage of firming rates. In addition, Walsh says RenaissanceRe is primed for strong growth and that Wall Street analysts will likely revise profit forecasts for the company higher in the near term.

Walsh notes that there were approximately 820 natural catastrophe events in 2011 with total insured losses of about $105 billion, making last year the second most costly since 1980. "While these losses were not sufficient to create a hard market, RNR is seeing solid price increases, which we would also define as adequate from an ROE perspective and sustainable in 2012 owing to increased demand for reinsurance," Walsh writes.

Additionally, Walsh said he expects RenaissanceRe to resume share buybacks. "Management has indicated share buy backs could resume beginning in 4Q11, making them one of a handful of underwriters that can write more business and return capital to shareholders," Walsh writes.

In addition to increasing his 2012 and 2013 profit estimates, Walsh reiterated his "buy" rating on RenaissanceRe and raised his price target to $85 from $80. In adding the stock to Citi's Top Picks Live! List, Walsh removed rival insurer XL Group (XL - Get Report), although Citi still retains a "buy" rating on the stock. Shares of RenaissanceRe closed Thursday at $72.97.

Meanwhile, Wells Fargo analyst John Hall upgraded RenaissanceRe to "outperform" from "market perform," arguing the company has set conservative guidance for 10% growth in its managed cat premiums in 2012. "Additionally RNR has proven that it can utilize multiple capital resources to take advantage of market opportunities," Hall adds.

Hall also upgraded Travelers (TRV - Get Report) to "outperform," saying the Dow component is "positioned to capitalize on the improving rates in the primary insurance market." Meanwhile, Hall downgraded Axis Capital (AXS - Get Report) to "market perform," arguing that a reversion to the mean for the company's share price may be extended due to the transition of CEO John Charman to the chairman position in May.

Hall raised his valuation range for RenaissanceRe to a range of $82 to $86 from the previous range of $72 to $76. He also increased his valuation range for Travelers to $67 to $72 from the prior valuation range of $60 to $65. Axis Capital's valuation range was cut to $32 to $35 from the previous range of $36 to $39.

-- Written by Robert Holmes in Boston.

>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to

>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AXS $53.27 0.00%
RNR $110.91 0.00%
TRV $109.90 0.00%
XL $32.73 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs